These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9459146)

  • 1. Multiparameter analysis of vasculature, perfusion and proliferation in human tumour xenografts.
    Bussink J; Kaanders JH; Rijken PF; Martindale CA; van der Kogel AJ
    Br J Cancer; 1998; 77(1):57-64. PubMed ID: 9459146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-12 has no effect on vascular density, perfusion, hypoxia and proliferation of an implanted human squamous cell carcinoma xenograft tumour despite up-regulation of ICAM-1.
    van Herpen CM; Bussink J; van der Kogel AJ; Peeters WJ; van der Voort R; van Schijndel A; de Wilde PC; Adema GJ; de Mulder PH
    Anticancer Res; 2005; 25(2A):1015-21. PubMed ID: 15868941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular architecture and microenvironmental parameters in human squamous cell carcinoma xenografts: effects of carbogen and nicotinamide.
    Bussink J; Kaanders JH; Rijken PF; Peters JP; Hodgkiss RJ; Marres HA; van der Kogel AJ
    Radiother Oncol; 1999 Feb; 50(2):173-84. PubMed ID: 10368041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular architecture, hypoxia, and proliferation in first-generation xenografts of human head-and-neck squamous cell carcinomas.
    Ljungkvist AS; Bussink J; Rijken PF; Kaanders JH; van der Kogel AJ; Denekamp J
    Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):215-28. PubMed ID: 12182995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct comparison of bromodeoxyuridine and Ki-67 labelling indices in human tumours.
    Wilson GD; Saunders MI; Dische S; Daley FM; Robinson BM; Martindale CA; Joiner B; Richman PI
    Cell Prolif; 1996 Mar; 29(3):141-52. PubMed ID: 8652743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of BrdUrd and [3H]TdR incorporation to estimate cell proliferation, cell loss, and potential doubling time in tumor xenografts.
    Zätterström UK; Johansson M; Källén A; Baldetorp B; Oredsson S; Wennerberg J; Killander D
    Cytometry; 1992; 13(8):872-9. PubMed ID: 1459003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell kinetic analysis of murine squamous cell carcinomas: a comparison of single versus double labelling using flow cytometry and immunohistochemistry.
    Schultz-Hector S; Begg AC; Hofland I; Kummermehr J; Sund M
    Br J Cancer; 1993 Dec; 68(6):1097-103. PubMed ID: 8260360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of an image analysis system to the quantitation of tumor perfusion and vascularity in human glioma xenografts.
    Rijken PF; Bernsen HJ; van der Kogel AJ
    Microvasc Res; 1995 Sep; 50(2):141-53. PubMed ID: 8538495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour growth rates in squamous carcinoma of the head and neck measured by in vivo bromodeoxyuridine incorporation and flow cytometry.
    Forster G; Cooke TG; Cooke LD; Stanton PD; Bowie G; Stell PM
    Br J Cancer; 1992 May; 65(5):698-702. PubMed ID: 1586597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour proliferation assessed by combined histological and flow cytometric analysis: implications for therapy in squamous cell carcinoma in the head and neck.
    Bennett MH; Wilson GD; Dische S; Saunders MI; Martindale CA; Robinson BM; O'Halloran AE; Leslie MD; Laing JH
    Br J Cancer; 1992 Jun; 65(6):870-8. PubMed ID: 1616858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal conditions for immunohistochemical determination of the in vitro DNA synthesis labelling index with bromodeoxyuridine in head and neck cancer.
    Browman GP; Kanclerz A; Booker L; Daya D; Archibald SD; Young JE; Goldsmith CH
    Cell Prolif; 1991 Nov; 24(6):579-85. PubMed ID: 1764538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies with bromodeoxyuridine in head and neck cancer and accelerated radiotherapy.
    Wilson GD; Dische S; Saunders MI
    Radiother Oncol; 1995 Sep; 36(3):189-97. PubMed ID: 8532905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular architecture and hypoxic profiles in human head and neck squamous cell carcinomas.
    Wijffels KI; Kaanders JH; Rijken PF; Bussink J; van den Hoogen FJ; Marres HA; de Wilde PC; Raleigh JA; van der Kogel AJ
    Br J Cancer; 2000 Sep; 83(5):674-83. PubMed ID: 10944611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferation and micromilieu during fractionated irradiation of human FaDu squamous cell carcinoma in nude mice.
    Petersen C; Eicheler W; Frömmel A; Krause M; Balschukat S; Zips D; Baumann M
    Int J Radiat Biol; 2003 Jul; 79(7):469-77. PubMed ID: 14530154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatial relationship between hypoxia and the (perfused) vascular network in a human glioma xenograft: a quantitative multi-parameter analysis.
    Rijken PF; Bernsen HJ; Peters JP; Hodgkiss RJ; Raleigh JA; van der Kogel AJ
    Int J Radiat Oncol Biol Phys; 2000 Sep; 48(2):571-82. PubMed ID: 10974478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study of the effects of mild systemic heating on human head and neck tumour xenografts: Analysis of tumour perfusion, interstitial fluid pressure, hypoxia and efficacy of radiation therapy.
    Winslow TB; Eranki A; Ullas S; Singh AK; Repasky EA; Sen A
    Int J Hyperthermia; 2015; 31(6):693-701. PubMed ID: 25986432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-localisation of hypoxia and perfusion markers with parameters of glucose metabolism in human squamous cell carcinoma (hSCC) xenografts.
    Yaromina A; Quennet V; Zips D; Meyer S; Shakirin G; Walenta S; Mueller-Klieser W; Baumann M
    Int J Radiat Biol; 2009 Nov; 85(11):972-80. PubMed ID: 19895274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tirapazamine causes vascular dysfunction in HCT-116 tumour xenografts.
    Huxham LA; Kyle AH; Baker JH; McNicol KL; Minchinton AI
    Radiother Oncol; 2006 Feb; 78(2):138-45. PubMed ID: 16455148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell proliferation in human tumour xenografts: measurement using antibody labelling against bromodeoxyuridine and Ki-67.
    Parkins CS; Bush C; Price P; Steel GG
    Cell Prolif; 1991 Mar; 24(2):171-9. PubMed ID: 2009320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymidine analogues to assess microperfusion in human tumors.
    Janssen HL; Ljungkvist AS; Rijken PF; Sprong D; Bussink J; van der Kogel AJ; Haustermans KM; Begg AC
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1169-75. PubMed ID: 15990022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.